Who invested in Cardiol Therapeutics?
Cardiol Therapeutics's investors include Canaccord Genuity Group.

Canada · Funded startup
Funding summaryUpdated 26 Oct 2026
$7.0Mraised across 1 round since 2026, from 1 source
Cardiol Therapeutics's investors include Canaccord Genuity Group.
Cardiol Therapeutics has raised $7.0M across 1 round since 2026.
Cardiol Therapeutics's most recent round was an Undisclosed round of $7.0M in Sept 2026.
Its most recent round, $7.0M in Sept 2026, is also its largest on record.
Cardiol Therapeutics's first round on record, in Sept 2026, was backed by Canaccord Genuity Group.
Cardiol Therapeutics's latest named round is an Undisclosed round, in Sept 2026.
Cardiol Therapeutics is based in Canada.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.